Homepage - Synbora

Pioneering Innovation in Digital Health Technologies

Bern, May 2025: Synbora has officially filed its foundational Intellectual Property application for a novel AI-driven system that supports real-time cardiovascular health monitoring and behavior-guided interventions. This milestone marks a critical step toward protecting core innovations that integrate upper-arm reflectance PPG sensing, multimodal AI, and real-time feedback loops for chronic disease prevention. Discover how our invention is shaping the future of preventive digital medicine.

Subscribe to our newsletter!

Therapies for Chronic Diseases Prevention in Cardiovascular Health

Bern, January 2025: Synbora has started its proof-of-concept activities to develop personalized therapies for Cardiovascular Disease prevention in partnership with renowned Swiss institutions and Innovation Programs. Learn more about groundbreaking advancements in preventive health!

Get in Contact!

New Offices at the Insel Campus: Heart of Healthcare Innovation

Bern, January 2025: SYNBORA is proud to announce our new offices at the SITEM Startup Club and Insel Campus of Bern, a leading hub for healthcare innovation. This strategic location enables close collaboration with top healthcare professionals, researchers, and industry experts, fueling clinical and development breakthroughs.

Get in Contact!

Joining Major MedTech Innovation Programs!

Bern, December 2024: Synbora is proud to join major Swiss MedTech innovation programs, including SITEM TMBE, MedTech Booster, and Be-Advanced. Together, we’re shaping the future of preventive health and longevity.

Subscribe to the newsletter!

Extending access to Health Monitoring powered by CSEM Sensor Technology

Bern, November 2024: Synbora is thrilled to partner with CSEM for its future POC in Chronic Disease Prevention, a global leader in sensor technology, to provide medical grade wearable solutions. This collaboration highlights our dedication to cutting-edge technology, paving the way for groundbreaking advancements in preventive care innovation.

Get in Contact!

Clinical Research in Chronic Diseases Prevention at Insel REHA Zentrum

Bern, November 2024: Synbora is proud to join forces with Insel REHA Zentrum, a prestigious Swiss institution in Chronic Disease rehabilitation and Clinical Research. Together, we’re driving innovation in therapies for chronic disease prevention and management, reinforcing our commitment to better health outcomes.

Subscribe to the newsletter!

cardiovascular Diseases (CVD)

A Major Cardiovascular Recurrence Has Severe Consequences

A single major cardiovascular event place a significant financial burden on individuals and healthcare systems. Yet, despite the risks, a large number of patients do not adhere to preventive care after rehabilitation, leading a large portion of those CVD patients to another major CVD event, and vulnerable to further complications.

The reality is stark—up to 35% of survivors will experience a recurrence of major CVD events, facing an ongoing cycle of health challenges. Many are left with lasting disabilities, losing up to 10 healthy years of life. Prevention isn’t just an option—it’s the key to protecting your future.

Our Future Solution

SYNBORA™ System

The first system designed to deliver personalized digital therapeutics (DTx) driven by continuous cardiovascular disease (CVD) risk stratification.

Currently in prototyping (patent pending).

Future Capabilities

Designed for self-managed and clinician-supervised use cases of conditions such as hypertension, arrhythmia, heart failure, metabolic syndrome, autonomic dysfunction, post-stroke cognitive impairment, and post-viral fatigue. It includes:

Digital Nurse

Adaptive therapy based on biomarkers and contextual data

Wearable Device

Device integrating multi-parameter sensing & calibration free BP

Clinician App

Real-time oversight, AI-assisted decision support, and audit trail.

Behavioral Guidance

Dedicated AI-driven behavioral interventions and ChatBot.

Health Portal

Real-time patient data visualization and AI-powered risk stratification.

Predictive Analytics

AI-Powered Risk Prediction & Cloud-Based Data Intelligence

Our Vision

At SYNBORA, we aspire to a more vibrant society and workforce, where healthspan is a foundational aspect of people's life.

Our Mission

Our mission is to extend healthy lifespans of individuals with, or at elevated risk of cardiovascular diseases (CVD), by enabling continuous physiological monitoring and real-time therapy personalization.

Our Approach

SYNBORA applies First-Principles Thinking, tackling Chronic Disease at its root, delivering transformative and lasting health outcomes.

Meet the founders

At the core of SYNBORA’s mission are its founders, whose journey embodies perseverance, innovation, and a shared dedication to transforming lives.

Germano Meier

Co-Founder & Chief Executive Officer (CEO)

MedTech executive with over 15 years of experience leading CE- and FDA-cleared product development across diagnostics, implantable devices, and drug delivery systems, including senior roles at Novartis and Bio-Rad, and Onward Medical. Holds an MSc and an MBA, with background as a Medical Systems and Electronics developer.

Dr. med. Isabella Meier

Co-Founder & Chief Scientific Officer (CSO)

Anesthesiologist and pre-clinical emergency physician with more than a decade of frontline expertise in cardiopulmonary and cardiovascular patient care at the Insel University Hospital and REGA.

Christian Martin

Co-Founder & Chief Business Officer (CBO)

Business leader with over 18 years of experience in biotechnology, life sciences, and health innovation, including executive roles at Fermentalg, Veramaris, DSM, and Martek Biosciences. Holds an MBA, an MSc in Biotechnology, and a BS in Neurobiology and Physiology.

Rado Andrian

Co-Founder & Chief Technology Officer (CTO)

Digital health and AI key opinion leader with 20+ years of experience leading innovation for CE- and FDA-cleared products in Pharma and MedTech, including senior positions at Novartis, Biogen, and Capgemini. Holds an Executive MBA, MSc in Digital Signal & Image Processing, and advanced specialization in AI for Medical Applications.

Cardiovascular Diseases Prevention

Breaking the Cycle

Overwhelmed by endless health advice—strict diets, exercise plans, quitting smoking, and stress management—many struggle to keep up. A busy life leaves little room for self-care, leading to anxiety, procrastination, and the cycle of inconsistent efforts and old habits. Each setback reinforces feelings of failure, making change seem impossible.

Avoiding regular check-ups, early signs of declining health go unnoticed. Rationalizing inaction becomes easier, until another heart attack strikes.

It doesn’t have to be this way. Personalized guidance, and real-time health tracking can prevent setbacks, enabling patients to take control, and build a future of lasting heart health.

Empowering Patients with Vitality!

Integrating post-discharge patient history and biometric tracking, our team collaborates with specialists to design personalized digital therapies that integrates heart-healthy nutrition, stress management, physical optimization and injury prevention. With SYNBORA’s prevention-focused approach, patients gain the tools to stay active, independent, and heart-healthy, ensuring long-term vitality and well-being.

Insel Campus of Bern

R&D Office at the Insel-Campus

Located at a recognized hub for healthcare innovation where MedTech clinical and development activities in proximity with leading healthcare professionals, researchers, and industry experts.